import { H2, H3, P, UL, LI, Callout, ResearchNote } from "@/components/blog/article-prose"
import type { BlogPost } from "@/lib/blog/types"

const meta = {
  slug: "bpc-157-vs-tb-500",
  title: "BPC-157 vs TB-500: Comparing Two Tissue-Repair Peptides Studied in Research",
  description:
    "BPC-157 and TB-500 (a synthetic fragment of Thymosin Beta-4) are the two peptides most frequently compared in tissue-repair research. This article walks through their structural differences, distinct mechanisms of action in animal models, and why researchers sometimes study them in parallel.",
  publishedAt: "2026-05-15",
  author: "PrimeHelix Labz Research Team",
  readMinutes: 8,
  tags: ["BPC-157", "TB-500", "Thymosin Beta-4", "comparison"],
} as const

function Article() {
  return (
    <>
      <Callout>
        For in-vitro and laboratory research only. PrimeHelix Labz does not
        provide guidance on human use of any compound discussed below.
      </Callout>

      <P>
        BPC-157 and TB-500 are the two peptides most frequently mentioned in
        the same breath in tissue-repair research forums and review papers.
        They are often confused, partly because both have shown effects in
        wound-healing animal models and partly because they are sometimes
        used in parallel in preclinical studies. They are, however,
        structurally and mechanistically very different molecules. This
        article walks through the differences.
      </P>

      <H2>What each molecule actually is</H2>
      <H3>BPC-157</H3>
      <P>
        BPC-157 is a synthetic 15&ndash;amino-acid pentadecapeptide. It is a
        partial sequence of a larger protective protein originally isolated
        from human gastric juice. It does not exist as a free molecule in
        nature in this form&mdash;it is an engineered fragment selected for
        its activity in injury models. For a deeper overview of BPC-157, see
        our{" "}
        <a className="text-primary underline" href="/blog/bpc-157-research-guide">
          BPC-157 research guide
        </a>
        .
      </P>

      <H3>TB-500</H3>
      <P>
        &ldquo;TB-500&rdquo; is the research-supply name for a synthetic
        17&ndash;amino-acid fragment (residues 17&ndash;23 of the parent
        sequence, plus modifications, depending on supplier) of Thymosin
        Beta-4 (T&beta;4). T&beta;4 itself is a naturally occurring
        43&ndash;amino-acid protein found in nearly all human cells; it is one
        of the most abundant intracellular actin-sequestering proteins in
        mammals.
      </P>
      <P>
        It is important to note that TB-500 is not biologically identical to
        full-length T&beta;4. It contains the active actin-binding sequence
        but lacks much of the surrounding structure. Some published studies
        use full T&beta;4; many supply catalogs sell only the truncated TB-500
        fragment. Reading the COA carefully is therefore important.
      </P>

      <H2>Side-by-side comparison</H2>
      <div className="my-8 overflow-x-auto rounded-2xl border border-gray-200 bg-white">
        <table className="min-w-full text-left text-sm">
          <thead className="bg-gray-50 text-foreground">
            <tr>
              <th className="px-4 py-3 font-semibold">Attribute</th>
              <th className="px-4 py-3 font-semibold">BPC-157</th>
              <th className="px-4 py-3 font-semibold">TB-500</th>
            </tr>
          </thead>
          <tbody className="divide-y divide-gray-100 text-muted-foreground">
            <tr>
              <td className="px-4 py-3 font-medium text-foreground">Origin</td>
              <td className="px-4 py-3">Synthetic fragment of a gastric-juice protective protein</td>
              <td className="px-4 py-3">Synthetic fragment of Thymosin Beta-4 (T&beta;4)</td>
            </tr>
            <tr>
              <td className="px-4 py-3 font-medium text-foreground">Length</td>
              <td className="px-4 py-3">15 amino acids</td>
              <td className="px-4 py-3">~17 amino acids (sequence varies by supplier)</td>
            </tr>
            <tr>
              <td className="px-4 py-3 font-medium text-foreground">Approx. molecular weight</td>
              <td className="px-4 py-3">~1419.5 Da</td>
              <td className="px-4 py-3">~1900 Da</td>
            </tr>
            <tr>
              <td className="px-4 py-3 font-medium text-foreground">Primary mechanisms studied</td>
              <td className="px-4 py-3">VEGFR2 / angiogenic signaling, NO pathway, growth-factor receptor expression</td>
              <td className="px-4 py-3">Actin sequestration, cell migration, anti-inflammatory pathways</td>
            </tr>
            <tr>
              <td className="px-4 py-3 font-medium text-foreground">Common research models</td>
              <td className="px-4 py-3">Tendon and ligament repair, gastric ulcer, IBD models</td>
              <td className="px-4 py-3">Cardiac repair, dermal wound, corneal injury</td>
            </tr>
            <tr>
              <td className="px-4 py-3 font-medium text-foreground">Stability (lyophilized, &minus;20&deg;C)</td>
              <td className="px-4 py-3">~24&ndash;36 months</td>
              <td className="px-4 py-3">~24&ndash;36 months</td>
            </tr>
          </tbody>
        </table>
      </div>

      <H2>Mechanism of action: the core difference</H2>
      <P>
        BPC-157 has been studied primarily for its angiogenic and
        growth-factor-modulating effects&mdash;in other words, the published
        rodent literature reports increased blood-vessel formation and altered
        expression of growth-factor receptors at injury sites.
      </P>
      <P>
        TB-500 (and its parent T&beta;4) has been studied primarily for actin
        sequestration and cell migration. Actin is a structural protein
        critical to cell motility; T&beta;4 binds monomeric actin (G-actin)
        and is implicated in cell migration during wound repair, particularly
        of endothelial and epithelial cells.
      </P>
      <ResearchNote>
        These are two different mechanisms studied in different model systems.
        Direct head-to-head comparative studies in the same injury model and
        species are rare in the published literature.
      </ResearchNote>

      <H2>Why are they often discussed together?</H2>
      <P>
        Three reasons:
      </P>
      <UL>
        <LI>
          Both have appeared in animal-model tissue-repair literature, so
          search results overlap.
        </LI>
        <LI>
          Both are commercially available from research-peptide suppliers in
          comparable lyophilized form factors.
        </LI>
        <LI>
          Some preclinical and observational research protocols evaluate the
          two in parallel to compare angiogenic vs. cell-migration effects.
        </LI>
      </UL>

      <H2>Practical sourcing considerations</H2>
      <UL>
        <LI>
          <strong>Sequence verification.</strong> For TB-500 in particular,
          insist on a COA that specifies the exact peptide sequence supplied,
          since &ldquo;TB-500&rdquo; is a trade name rather than a strict
          chemical identifier.
        </LI>
        <LI>
          <strong>Purity.</strong> Both peptides are commonly supplied at
          &ge;98% purity by HPLC. Lower purities can complicate
          interpretation of model results.
        </LI>
        <LI>
          <strong>Storage.</strong> Both should be kept lyophilized at
          &minus;20&deg;C and reconstituted shortly before use.
        </LI>
      </UL>

      <H2>Further reading</H2>
      <P>
        For deeper background on either peptide individually, see our{" "}
        <a className="text-primary underline" href="/blog/bpc-157-research-guide">
          BPC-157 research guide
        </a>{" "}
        and{" "}
        <a className="text-primary underline" href="/blog/peptide-storage-guide">
          peptide storage guide
        </a>
        . If you are evaluating a new vendor, our{" "}
        <a className="text-primary underline" href="/blog/how-to-read-peptide-coa">
          guide to reading a Certificate of Analysis
        </a>{" "}
        is worth reviewing first.
      </P>

      <Callout>
        <strong>Reminder:</strong> Information above summarizes preclinical
        research literature for laboratory and educational purposes only. It is
        not medical advice, and these compounds are not intended for human use.
      </Callout>
    </>
  )
}

const post: BlogPost = {
  ...meta,
  Component: Article,
}

export default post
